Goldman Sachs
MGRX icon

Goldman Sachs’s Mangoceuticals MGRX Stock Holding History

Goldman Sachs’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.4K Sell
11,589
-168
-1% -$65 ﹤0.01% 6500
2026
Q1 		$4.23K Buy
+11,757
New +$5.63K ﹤0.01% 6403
2025
Q3 		– Sell
-10,570
Closed -$16.1K – 6539
2025
Q2 		$16.1K Buy
+10,570
New +$19.8K ﹤0.01% 5996
2024
Q4 		– Sell
-679
Closed -$2.4K – 6180
2024
Q3 		$2.4K Buy
+679
New +$3.2K ﹤0.01% 5763

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Goldman Sachs's MGRX Position: Q2 2026 in Review

Goldman Sachs reduced its Mangoceuticals (MGRX) stake by 1.4% in Q2 2026, selling an estimated $65 and leaving 11,589 shares worth $4.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6500.

Goldman Sachs first reported a position in MGRX in Q3 2024 and has held it in 4 quarters since. The position peaked at $16.1K in Q2 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Goldman Sachs held 11,589 shares of Mangoceuticals worth $4.4K as of Q2 2026.
  • Goldman Sachs sold 168 Mangoceuticals shares in Q2 2026, an estimated $65.
  • Mangoceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6500 holding.
  • Goldman Sachs first reported a position in Mangoceuticals in Q3 2024 and has held it in 4 quarters since.
  • Goldman Sachs's Mangoceuticals position peaked at $16.1K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.